Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Interferon-Alpha and Caffeine

supplement:

Caffeine

Research Papers that Mention the Interaction

“Regarding cytokine analysis, a negative correlation between daily caffeine consumption and serum level of IFNγ … found (p = 0.03, r = –0.2); furthermore, patients with a high intake of caffeine showed lower … levels of IFNα (p = 0.02), IL-17 (p = 0.01) and IL-6 (p = 0.003).”
Lupus  •  2020  |  View Paper
“ Caffeine was found to potentiate the X-ray-induced aberration yield in both normal fibroblast and lymphoblastoid cells.”
Human Genetics  •  2004  |  View Paper
“Here we report that caffeine potentiates the induction of chromosomal breaks in G2 arrested AT heterozygote and normal lymphoblastoid cells , but not in homozygous AT lymphoblastoid cells.”
Mutation research  •  1998  |  View Paper
“ Alpha-interferon has shown synergism with other anti-HSV drugs such as caffeine , trifluorothymidine (TFT), DMSO, and nonoxynol-9.”
European journal of dermatology : EJD  •  1998  |  View Paper
“We found that caffeine and anti-PD1 mAb combination therapy significantly increased intra-tumoral TNF-α and IFN-γ levels.”
International immunopharmacology  •  2019  |  View Paper
“Intranasal administration of the adenosine receptor antagonist caffeine substantially enhanced the frequency and number of parenchymal CD4+ T cells as well as both CD69 expression and IFNγ production.”
The Journal of infectious diseases  •  2019  |  View Paper
“ Interferon-alpha has shown synergism with other anti-HSV drugs such as caffeine , trifluorothymidine, dimethyl sulfoxide and nonoxynol-9, and ascorbic acid shows promising effects against HSV.”
Drugs of today  •  1998  |  View Paper